1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19
on Global Rare Disease Diagnostics Market
5. Voice of Customer
6.
Global Rare Disease Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Indication (Gastroenterology Disease, Endocrine &
Metabolism Disorders Disease, Cardiovascular Disorders, Hematology &
Oncology Disease, Others)
6.2.2. By Trait Type (Inherited v/s Acquired)
6.2.3. By Test Type (Genetic Tests, General Lab Tests,
Diagnostic Imaging, Others)
6.2.4. By Technology (Next Generation Sequencing, Whole Genome
Sequencing, Whole Exome Sequencing, Microarrays, Others)
6.2.5. By Sample Type (DNA Sample, Blood Sample, Saliva Sample,
Others)
6.2.6. By End User (Hospitals & Clinics, Academic &
Research Institutes, Others)
6.2.7. By Region
6.2.8. By Company (2021)
6.3. Market Map
7.
North America Rare Disease Diagnostics Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1. By Indication
7.2.2. By Trait Type
7.2.3. By Test Type
7.2.4. By Technology
7.2.5. By Sample Type
7.2.6. By End User
7.2.7. By Country
7.3. North America:
Country Analysis
7.3.1. United States Rare
Disease Diagnostics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Indication
7.3.1.2.2.
By Trait Type
7.3.1.2.3.
By Test Type
7.3.1.2.4.
By Technology
7.3.1.2.5.
By Sample Type
7.3.1.2.6.
By End User
7.3.2. Canada Rare Disease
Diagnostics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Indication
7.3.2.2.2.
By Trait Type
7.3.2.2.3.
By Test Type
7.3.2.2.4.
By Technology
7.3.2.2.5.
By Sample Type
7.3.2.2.6.
By End User
7.3.3. Mexico Rare Disease
Diagnostics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Indication
7.3.3.2.2.
By Trait Type
7.3.3.2.3.
By Test Type
7.3.3.2.4.
By Technology
7.3.3.2.5.
By Sample Type
7.3.3.2.6.
By End User
8.
Europe Rare Disease Diagnostics Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1. By Indication
8.2.2. By Trait Type
8.2.3. By Test Type
8.2.4. By Technology
8.2.5. By Sample Type
8.2.6. By End User
8.2.7. By Country
8.3. Europe: Country
Analysis
8.3.1. France Rare Disease
Diagnostics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Indication
8.3.1.2.2.
By Trait Type
8.3.1.2.3.
By Test Type
8.3.1.2.4.
By Technology
8.3.1.2.5.
By Sample Type
8.3.1.2.6.
By End User
8.3.2. Germany Rare Disease
Diagnostics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Indication
8.3.2.2.2.
By Trait Type
8.3.2.2.3.
By Test Type
8.3.2.2.4.
By Technology
8.3.2.2.5.
By Sample Type
8.3.2.2.6.
By End User
8.3.3. United Kingdom Rare
Disease Diagnostics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Indication
8.3.3.2.2.
By Trait Type
8.3.3.2.3.
By Test Type
8.3.3.2.4.
By Technology
8.3.3.2.5.
By Sample Type
8.3.3.2.6.
By End User
8.3.4. Italy Rare Disease
Diagnostics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Indication
8.3.4.2.2.
By Trait Type
8.3.4.2.3.
By Test Type
8.3.4.2.4.
By Technology
8.3.4.2.5.
By Sample Type
8.3.4.2.6.
By End User
8.3.5. Spain Rare Disease
Diagnostics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Indication
8.3.5.2.2.
By Trait Type
8.3.5.2.3.
By Test Type
8.3.5.2.4.
By Technology
8.3.5.2.5.
By Sample Type
8.3.5.2.6.
By End User
9.
Asia-Pacific Rare Disease Diagnostics Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1. By Indication
9.2.2. By Trait Type
9.2.3. By Test Type
9.2.4. By Technology
9.2.5. By Sample Type
9.2.6. By End User
9.2.7. By Country
9.3. Asia-Pacific:
Country Analysis
9.3.1. China Rare Disease
Diagnostics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Indication
9.3.1.2.2.
By Trait Type
9.3.1.2.3.
By Test Type
9.3.1.2.4.
By Technology
9.3.1.2.5.
By Sample Type
9.3.1.2.6.
By End User
9.3.2. India Rare Disease
Diagnostics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Indication
9.3.2.2.2.
By Trait Type
9.3.2.2.3.
By Test Type
9.3.2.2.4.
By Technology
9.3.2.2.5.
By Sample Type
9.3.2.2.6.
By End User
9.3.3. Japan Rare Disease
Diagnostics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Indication
9.3.3.2.2.
By Trait Type
9.3.3.2.3.
By Test Type
9.3.3.2.4.
By Technology
9.3.3.2.5.
By Sample Type
9.3.3.2.6.
By End User
9.3.4. South Korea Rare
Disease Diagnostics Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Indication
9.3.4.2.2.
By Trait Type
9.3.4.2.3.
By Test Type
9.3.4.2.4.
By Technology
9.3.4.2.5.
By Sample Type
9.3.4.2.6.
By End User
9.3.5. Australia Rare
Disease Diagnostics Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Indication
9.3.5.2.2.
By Trait Type
9.3.5.2.3.
By Test Type
9.3.5.2.4.
By Technology
9.3.5.2.5.
By Sample Type
9.3.5.2.6.
By End User
10.
South America Rare Disease Diagnostics Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Indication
10.2.2. By Trait Type
10.2.3. By Test Type
10.2.4. By Technology
10.2.5. By Sample Type
10.2.6. By End User
10.2.7. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Rare Disease
Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Indication
10.3.1.2.2.
By Trait Type
10.3.1.2.3.
By Test Type
10.3.1.2.4.
By Technology
10.3.1.2.5.
By Sample Type
10.3.1.2.6.
By End User
10.3.2. Argentina Rare
Disease Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Indication
10.3.2.2.2.
By Trait Type
10.3.2.2.3.
By Test Type
10.3.2.2.4.
By Technology
10.3.2.2.5.
By Sample Type
10.3.2.2.6.
By End User
10.3.3. Colombia Rare
Disease Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Indication
10.3.3.2.2.
By Trait Type
10.3.3.2.3.
By Test Type
10.3.3.2.4.
By Technology
10.3.3.2.5.
By Sample Type
10.3.3.2.6.
By End User
11.
Middle East and Africa Rare Disease Diagnostics Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Indication
11.2.2. By Trait Type
11.2.3. By Test Type
11.2.4. By Technology
11.2.5. By Sample Type
11.2.6. By End User
11.2.7. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa Rare
Disease Diagnostics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Indication
11.3.1.2.2.
By Trait Type
11.3.1.2.3.
By Test Type
11.3.1.2.4.
By Technology
11.3.1.2.5.
By Sample Type
11.3.1.2.6.
By End User
11.3.2. Saudi Arabia Rare
Disease Diagnostics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Indication
11.3.2.2.2.
By Trait Type
11.3.2.2.3.
By Test Type
11.3.2.2.4.
By Technology
11.3.2.2.5.
By Sample Type
11.3.2.2.6.
By End User
11.3.3. UAE Rare Disease
Diagnostics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Indication
11.3.3.2.2.
By Trait Type
11.3.3.2.3.
By Test Type
11.3.3.2.4.
By Technology
11.3.3.2.5.
By Sample Type
11.3.3.2.6.
By End User
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Competitive
Landscape (Inclusive of SWOT Analysis)
14.1.
Agilent Technologies, Inc.
14.2.
Illumina, Inc.
14.3.
QIAGEN NV
14.4.
PerkinElmer, Inc
14.5.
Quest Diagnostics, Inc.
14.6.
CENTOGENE N.V.
14.7.
23andMe, Inc.
14.8.
3billion, Inc.
14.9.
Eurofins Scientific SE
14.10.
Invitae Corporation
15. Strategic Recommendations